Cargando…
Nanomedicine against Aβ Aggregation by β–Sheet Breaker Peptide Delivery: In Vitro Evidence
The accumulation of amyloid β (Aβ) triggers a cascade of toxic events in Alzheimer’s disease (AD). The KLVFF peptide can interfere with Aβ aggregation. However, the peptide suffers from poor bioavailability and the inability to cross the blood–brain barrier. In this work, we study the possibility of...
Autores principales: | Pederzoli, Francesca, Ruozi, Barbara, Duskey, Jason, Hagmeyer, Simone, Sauer, Ann Katrin, Grabrucker, Stefanie, Coelho, Romina, Oddone, Natalia, Ottonelli, Ilaria, Daini, Eleonora, Zoli, Michele, Vandelli, Maria Angela, Tosi, Giovanni, Grabrucker, Andreas M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920811/ https://www.ncbi.nlm.nih.gov/pubmed/31683907 http://dx.doi.org/10.3390/pharmaceutics11110572 |
Ejemplares similares
-
Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments
por: Duskey, Jason Thomas, et al.
Publicado: (2022) -
Tunneling Nanotubes: A New Target for Nanomedicine?
por: Ottonelli, Ilaria, et al.
Publicado: (2022) -
Microfluidic Technology for the Production of Hybrid Nanomedicines
por: Ottonelli, Ilaria, et al.
Publicado: (2021) -
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles
por: Vilella, Antonietta, et al.
Publicado: (2015) -
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines
por: Rinaldi, Arianna, et al.
Publicado: (2022)